These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1183732)

  • 21. Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon.
    McGarry J; Wright PH; Foster DW
    J Clin Invest; 1975 Jun; 55(6):1202-9. PubMed ID: 1133169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid regulation of plasma ketone body concentration in insulin devicient man.
    Schade DS; Eaton RP; Standefer J
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1069-79. PubMed ID: 874044
    [No Abstract]   [Full Text] [Related]  

  • 23. The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic man.
    Schade DS; Eaton RP
    J Clin Endocrinol Metab; 1980 Jan; 50(1):131-6. PubMed ID: 7350176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
    Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
    Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High blood ketone body concentration in type 2 non-insulin dependent diabetic patients.
    Avogaro A; Crepaldi C; Miola M; Maran A; Pengo V; Tiengo A; Del Prato S
    J Endocrinol Invest; 1996 Feb; 19(2):99-105. PubMed ID: 8778173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ketotic ratio (KB/NEFA) in man.
    Schade DS; Eaton RP
    Clin Exp Pharmacol Physiol; 1981 Jul; 8(4):303-13. PubMed ID: 7307349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlations between NEFA and ketone bodies in normal and diabetic subjects].
    Odetti P; Diara C; Corsi L; Viviani G; Maiello M; Cordera R; De Micheli A; Prando R
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):146-52. PubMed ID: 7002170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose response to insulin in man: differential effects on glucose and ketone body regulation.
    Schade DS; Eaton RP
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1038-53. PubMed ID: 874043
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic control in diabetic pregnancy. Variations in plasma concentrations of glucose, free fatty acids, glycerol, ketone bodies, insulin, and human chorionic somatomammotropin during the last trimester.
    Persson B; Lunell NO
    Am J Obstet Gynecol; 1975 Jul; 122(6):737-45. PubMed ID: 1155514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid-independent inhibition of hepatic ketone body production by insulin in humans.
    Keller U; Gerber PP; Stauffacher W
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E694-9. PubMed ID: 3287950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
    Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose, free fatty acid and ketone body metabolism in Duchenne muscular dystrophy.
    Nishio H; Wada H; Matsuo T; Horikawa H; Takahashi K; Nakajima T; Matsuo M; Nakamura H
    Brain Dev; 1990; 12(4):390-402. PubMed ID: 2240459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal man.
    Schade DS; Eaton RP
    Diabetes; 1979 Jan; 28(1):5-10. PubMed ID: 759250
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of physiological concentrations of insulin and glucagon on the relationship between nonesterified fatty acids availability and ketone body production in humans.
    Beylot M; Picard S; Chambrier C; Vidal H; Laville M; Cohen R; Cotisson A; Mornex R
    Metabolism; 1991 Nov; 40(11):1138-46. PubMed ID: 1943742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of free fatty acids and ketone bodies during exercise in normal and diabetic man.
    Hagenfeldt L
    Diabetes; 1979 Jan; 28 Suppl 1():66-70. PubMed ID: 104895
    [No Abstract]   [Full Text] [Related]  

  • 38. Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes.
    Garg M; Ghanim H; Kuhadiya ND; Green K; Hejna J; Abuaysheh S; Torre B; Batra M; Makdissi A; Chaudhuri A; Dandona P
    Diabetes Obes Metab; 2017 Sep; 19(9):1306-1311. PubMed ID: 28304146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E
    Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis.
    Del Prato S; Riva F; Devidé A; Nosadini R; Fedele D; Tiengo A
    Acta Diabetol Lat; 1980; 17(2):111-8. PubMed ID: 7004039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.